Clinical Trials Browser

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

NCT05806515 2026-01-29

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Phase 2 Recruiting

44 enrolled

Genitourinary

Prostatic Neoplasms

NCT06470243 2026-01-22

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Phase 3 Recruiting

528 enrolled

Genitourinary

Prostatic Neoplasms

NCT05974774 2025-09-19

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

Phase 3 Recruiting

1,600 enrolled

Genitourinary

Prostatic Neoplasms

NCT03678025 2025-09-11

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Phase 3 Recruiting

1,273 enrolled

Genitourinary

Prostatic Neoplasms

NCT00969111 2025-09-09

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Phase NA Recruiting

70 enrolled

Genitourinary

Prostatic Neoplasms

NCT04510597 2025-09-09

PROBE

Phase 3 Recruiting

364 enrolled

Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT01492972 2025-09-04

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Phase 3 Recruiting

192 enrolled

Genitourinary

Prostatic Neoplasms

NCT06462963 2025-08-01

SPRINT

Phase NA Recruiting

302 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06355336 2025-05-31

RWPCR

Recruiting

1,000 enrolled

Genitourinary

Prostatic Neoplasms

NCT06582628 2024-12-02

TEAM PC

Phase 2 Recruiting

78 enrolled

Genitourinary

Prostatic Diseases, Prostatic Neoplasms

NCT04498767 2024-08-26

OligoRARE

Phase NA Recruiting

200 enrolled

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma, Pancreatic Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms

NCT05563558 2024-06-11

PEAPOD_FOS

Phase 2 Recruiting

42 enrolled

Genitourinary

Prostate Cancer Metastatic

Clinical Trials

OPTION-DDR

ASCENDE-SBRT

TRIPLE-SWITCH

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

PROCARE

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

PROBE

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

SPRINT

RWPCR

TEAM PC

OligoRARE

PEAPOD_FOS